Cellular Autophagy
Sandoz bets on strong growth in biosimilars market
Sandoz aims to double net sales by 2035 with 100 biosimilars by 2040, capitalizing on patent expirations in the biosimilars market.
By Ava Brown · Sep 8, 2026
Tag: sector
Sleep Architecture
White House reaches deals with more pharmas
White House signs pricing deals with more pharmaceutical companies, including Alcon and Teva Pharma, to reduce drug prices in the US with pharma deals.
By Maumereng · Sep 1, 2026
Metabolic Markers
US Pharma Navigates Europe’s AI Regulatory Maze
Discover how US pharmaceutical companies navigate the complex EU AI Act regulations for AI deployment in European clinical trials and compliance.
By Maumereng · Aug 31, 2026